Cargando…
Successful treatment of heparin‐induced thrombocytopenia with apixaban in a patient with chronic kidney disease requiring hemodialysis
Heparin‐induced thrombocytopenia (HIT) is a prothrombotic state that can affect patients with chronic kidney disease (CKD) on hemodialysis (HD). This case highlights the potential usefulness of apixaban therapy for patients with HIT and CKD on HD.
Autores principales: | Trujillo Agudelo, Daniela, Ramirez Quintero, Juan D., Arango Barrientos, Marcos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6230604/ https://www.ncbi.nlm.nih.gov/pubmed/30455909 http://dx.doi.org/10.1002/ccr3.1817 |
Ejemplares similares
-
The Role of Apixaban in the Treatment of Heparin-Induced Thrombocytopenia
por: Khalid, Sidra, et al.
Publicado: (2017) -
Apixaban/heparin/rivaroxaban: Melaena and thrombocytopenia: 2 case reports
Publicado: (2020) -
Heparin-Induced Thrombocytopenia in Chronic Hemodialysis
Patients
por: Hamadi, Rachelle, et al.
Publicado: (2023) -
Apixaban for treatment of confirmed heparin-induced thrombocytopenia: a case report and review of literature
por: Ezekwudo, Daniel E., et al.
Publicado: (2017) -
Apixaban used for the management of heparin‐induced thrombocytopenia in a 72‐year‐old woman with lung cancer
por: Larsen, Pia Bükmann, et al.
Publicado: (2015)